Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biofabrication of Hierarchical Medium-Sized Branched Blood Vessel Scaffolds Utilising Negative Embodied Sacrificial Template 3D and Human-Induced Pluripotent Stem Cells.

ACS biomaterials science & engineering·2026
Same author

Matrix type influences embedded patient-derived osteosarcoma organoid invasion and response to treatment.

Frontiers in pharmacology·2026
Same author

Effects of Eribulin on Epithelial-Mesenchymal Plasticity in Patient-Derived Breast Cancer Cultures and Excised Tissues.

Cancers·2026
Same author

Patient-derived osteosarcoma tumoroid model reveals functional phenotypic diversity with implications for drug responses.

Biofabrication·2026
Same author

Facilitating consumer partnerships in health research.

Journal of translational medicine·2025
Same author

EMT and cancer: what clinicians should know.

Nature reviews. Clinical oncology·2025

Related Experiment Video

Updated: Jul 18, 2026

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
08:53

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

Published on: November 2, 2016

An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct.

Zerina Lokmic1, Filip Stillaert, Wayne A Morrison

  • 1Bernard O'Brien Institute of Microsurgery and University of Melbourne Department of Surgery, St. Vincent's Hospital, Melbourne, Victoria, Australia.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|December 19, 2006
PubMed
Summary

This study introduces an in vivo intrinsic vascularization model using an arteriovenous loop (AVL) to overcome vascularization challenges in tissue engineering. The model demonstrates robust microcirculatory development, identifying an optimal window for cell seeding in tissue engineering applications.

More Related Videos

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

Related Experiment Videos

Last Updated: Jul 18, 2026

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
08:53

The Arteriovenous (AV) Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

Published on: November 2, 2016

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber
09:55

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Vascular Biology

Background:

  • 3D tissue engineering faces challenges in vascularizing engineered tissues.
  • An in vivo intrinsic vascularization model using an arteriovenous loop (AVL) within a polycarbonate chamber is proposed to address this.
  • This model creates a protected space for spontaneous microcirculatory development.

Purpose of the Study:

  • To examine vascular development and hypoxia in an in vivo intrinsic vascularization model.
  • To understand vascular growth and remodeling parameters for tissue engineering applications.
  • To identify optimal timing for cell seeding in the model.

Main Methods:

  • Vascular casting, morphometric, and morphological techniques were employed.
  • Vascular development and hypoxia were analyzed from 3 to 112 days.
  • Cellular and vascular changes were quantified over time.

Main Results:

  • A fibrin scaffold supported cell migration by day 3.
  • Capillary formation occurred between days 3 and 7.
  • Peak vascular volume (23.20%) and cell proliferation were observed around days 7-10.
  • Maximal apoptosis occurred at 112 days.

Conclusions:

  • The model facilitates spontaneous microcirculatory development within a protected environment.
  • An optimal temporal window for exogenous cell seeding exists between 7 and 10 days.
  • This model shows promise for in vivo tissue engineering applications.